371 related articles for article (PubMed ID: 3970138)
21. Characteristics of Sternberg-Reed, and related cells in Hodgkin's disease: an immunohistological study.
Dorreen MS; Habeshaw JA; Stansfeld AG; Wrigley PF; Lister TA
Br J Cancer; 1984 Apr; 49(4):465-76. PubMed ID: 6370286
[TBL] [Abstract][Full Text] [Related]
22. Hodgkin's disease revisited: Reed-Sternberg cells as natural hybridomas.
Sinkovics JG
Crit Rev Immunol; 1991; 11(1):33-63. PubMed ID: 1652972
[TBL] [Abstract][Full Text] [Related]
23. Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's disease.
Hsu SM; Jaffe ES
Am J Clin Pathol; 1984 Jul; 82(1):29-32. PubMed ID: 6741873
[TBL] [Abstract][Full Text] [Related]
24. The immunohistology of Hodgkin's disease--Reed-Sternberg cells and their variants.
Angel CA; Warford A; Campbell AC; Pringle JH; Lauder I
J Pathol; 1987 Sep; 153(1):21-30. PubMed ID: 3499498
[TBL] [Abstract][Full Text] [Related]
25. Hodgkin's disease: an immunohistochemical and histological study.
Curran RC; Jones EL
J Pathol; 1978 May; 125(1):39-51. PubMed ID: 569193
[TBL] [Abstract][Full Text] [Related]
26. Immunophenotype of Reed-Sternberg and Hodgkin's cells in sequential biopsy specimens of Hodgkin's disease: a paraffin-section immunohistochemical study using the heat-induced epitope retrieval method.
Vasef MA; Alsabeh R; Medeiros LJ; Weiss LM
Am J Clin Pathol; 1997 Jul; 108(1):54-9. PubMed ID: 9208978
[TBL] [Abstract][Full Text] [Related]
27. Hodgkin and Reed-Sternberg cell associated monoclonal antibodies HRS-1 and HRS-2 react with activated cells of lymphoid and monocytoid origin.
Pfreundschuh M; Mommertz E; Meissner M; Feller AC; Hassa R; Krueger GR; Diehl V
Anticancer Res; 1988; 8(2):217-24. PubMed ID: 3364933
[TBL] [Abstract][Full Text] [Related]
28. Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?
Brink AA; Oudejans JJ; van den Brule AJ; Kluin PM; Horstman A; Ossenkoppele GJ; van Heerde P; Jiwa M; Meijer CJ
Mod Pathol; 1998 Apr; 11(4):376-83. PubMed ID: 9578089
[TBL] [Abstract][Full Text] [Related]
29. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease.
Bai MC; Jiwa NM; Horstman A; Vos W; Kluin PH; Van der Valk P; Mullink H; Walboomers JM; Meijer CJ
J Pathol; 1994 Sep; 174(1):49-55. PubMed ID: 7525910
[TBL] [Abstract][Full Text] [Related]
30. Immunoreactivities of Reed-Sternberg cells and their variants in the sequential biopsy of Hodgkin's disease.
Ohsawa M; Aozasa K; Ikeda H
Mod Pathol; 1993 Jul; 6(4):457-62. PubMed ID: 8415592
[TBL] [Abstract][Full Text] [Related]
31. Nodular sclerosing, mixed cellularity and lymphocyte-depleted variants of Hodgkin's disease are probable dendritic cell malignancies.
Kennedy IC; Hart DN; Colls BM; Nimmo JC; Willis DA; Angus HB
Clin Exp Immunol; 1989 Jun; 76(3):324-31. PubMed ID: 2787713
[TBL] [Abstract][Full Text] [Related]
32. The reaction of xenogeneic and monoclonal antisera with Reed-Sternberg cells.
Stuart AE; Jackson E; Morris CS
J Pathol; 1982 Jun; 137(2):129-38. PubMed ID: 6979620
[TBL] [Abstract][Full Text] [Related]
33. Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens.
Kadin M; Nasu K; Sako D; Said J; Vonderheid E
Am J Pathol; 1985 May; 119(2):315-25. PubMed ID: 3158209
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
[TBL] [Abstract][Full Text] [Related]
35. Monomorphic lymphomas arising in patients with Hodgkin's disease. Correlation of morphologic, immunophenotypic, and molecular genetic findings in 12 cases.
Casey TT; Cousar JB; Mangum M; Williams ME; Lee JT; Greer JP; Collins RD
Am J Pathol; 1990 Jan; 136(1):81-94. PubMed ID: 2297052
[TBL] [Abstract][Full Text] [Related]
36. Hodgkin's disease, lymphocyte-predominant type: immunoreactivity with B-cell antibodies.
Coles FB; Cartun RW; Pastuszak WT
Mod Pathol; 1988 Jul; 1(4):274-8. PubMed ID: 3266337
[TBL] [Abstract][Full Text] [Related]
37. Paraffin section markers for Reed-Sternberg cells. A comparative study of peanut agglutinin, Leu-M1, LN-2, and Ber-H2.
Ree HJ; Neiman RS; Martin AW; Dallenbach F; Stein H
Cancer; 1989 May; 63(10):2030-6. PubMed ID: 2564804
[TBL] [Abstract][Full Text] [Related]
38. Classical Hodgkin and Reed-Sternberg cells demonstrate a non-clonal immature B lymphoid lineage: evidence from a single cell assay and in situ hybridization.
Ohshima K; Suzumiya J; Mukai Y; Tashiro K; Shibata T; Tanaka T; Kato A; Kikuchi M
Hematol Oncol; 1996 Sep; 14(3):123-36. PubMed ID: 9119357
[TBL] [Abstract][Full Text] [Related]
39. The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease.
Poppema S
Am J Pathol; 1989 Aug; 135(2):351-7. PubMed ID: 2675617
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel.
Chittal SM; Caverivière P; Schwarting R; Gerdes J; Al Saati T; Rigal-Huguet F; Stein H; Delsol G
Am J Surg Pathol; 1988 Jan; 12(1):9-21. PubMed ID: 2827535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
